Contagion Live: Nathan Berger, the Hanna-Payne Professor of Experimental Medicine at the School of Medicine, discussed new research that shows cancer patients have an enhanced risk of breakthrough COVID-19 infection. "The differential rate of breakthrough infection with different cancers does not comport with demonstrated deficiency in antibody response to mRNA vaccines, suggesting the additional importance of cell-mediated immunity and other host actors in resisting infection and determining disease susceptibility and severity," said Berger.
